Correlation Between Bioelectrical Impedance Analysis-Measured Body Fat, Body Mass Index and Waist Circumference with Cardiovascular Risk Factors in Acute Coronary Syndrome Patients
Versions
- 2021-09-30 (2)
- 2021-09-30 (1)
Downloads
Estimation of fat using bioelectrical impedance analysis (BIA) is thought to be a more predictive measure of cardiovascular (CV) risk assessment than body mass index (BMI) or waist circumference (WC). Percent body fat as measured using BIA (BIA-BF%) is independently associated with future cardiovascular events namely acute myocardial infarction, ischemic heart disease. This study is conducted to determine the correlation between body fat which consists of BIA-BF%, percentage of subcutaneous adipose tissue (SAT) and visceral fat level (Visceral Adipose Tissue/VAT) measured using BIA device, BMI and WC with CV risk factors (blood pressure, blood glucose level, LDL, HDL, TG, total cholesterol, HbA1c and serum fibrinogen) in patients with acute coronary syndrome (ACS). Material and Methods : This study used a cross-sectional correlation analysis. Sample was 70 ACS patients that match with inclusion criteria. Results : We found significant correlations between BIA-BF% with diastolic blood pressure, TG, and total cholesterol (r = 0.246, r = 0.250, r = 0.348 respectively; p <0.05). There was a significant correlation between VAT with diastolic blood pressure, LDL, TG, total cholesterol, HbA1c, and fibrinogen (r = 0.299, r = 0.306, r = 0.278, r = 0.265, r = 0.292, r = 0.330 respectively, p <0.05). There was a significant correlation between the percentage SAT and HDL levels (r = 0.318; p <0.05). We found no correlation between BMI and WC with blood pressure, LDL, HDL, TG, blood glucose, HbA1c and fibrinogen levels in ACS patients. Conclusion: VAT and BIA-BF% correlate with several cardiovascular risk factors better than BMI and WC. Body fat examination using BIA may be done to manage risk factors in ACS patients.
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2017;39(2):119–77.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37:2315–81.
Després J. Abdominal Obesity and Cardiovascular Disease : Is Inflammation the Missing Link ? CJCA. 2012;28(6):642–52.
Mongraw-Chaffin ML, Peters SAE, Huxley RR, Woodward M. The sex-specific association between BMI and coronary heart disease: a systematic review and meta-analysis of 95 cohorts with 1·2 million participants. Lancet Diabetes Endocrinol. 2015 Jun;3(6):437–49.
Frayn KN. Cardiovascular Disease Diet, Nutrition and Emerging Risk Factors. second. Stanner S, Coe S, editors. India: Blackwell Publishing; 2019.
Fox C, Massaro J, Hoffmann U, KM P, Horvat P, Liu C, et al. Abdominal Visceral and Subcutaneous Adipose Tissue Compartments. 2007 Jul;116(1):39–48.
Berker D, Koparal S, Işik S, Paşaoǧlu L, Aydin Y, Erol K, et al. Compatibility of different methods for the measurement of visceral fat in different body mass index strata. Diagnostic Interv Radiol. 2010;16(2):99–105.
Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, et al. Bioelectrical impedance analysis - Part I: Review of principles and methods. Clin Nutr. 2004;23(5):1226–43.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. The New 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019. CIRCULATIONAHA.119.040625.
Kemenkes RI. PETUNJUK TEKNIS POS PEMBINAAN TERPADU PENYAKIT TIDAK MENULAR (POSBINDU PTM). 2012;
Jennings C, Graham I, Gielen S. The ESC Handbook of Preventive Cardiology Putting Prevention into Practice. Oxford: Oxford University Press; 2016.
Byambasukh O, Eisenga MF, Gansevoort RT, Bakker SJL, Corpeleijn E. Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study. Eur J Prev Cardiol. 2019;
Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of . Eur Heart J. 2016;37(3):267–315.
Elagizi A, Kachur S, Lavie CJ, Carbone S, Pandey A, Ortega FB, et al. An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases. Prog Cardiovasc Dis. 2018;61(2):142–50.
Kadakia MB, Fox CS, Scirica BM, Murphy SA, Bonaca MP, Morrow DA. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: Observations from the MERLIN-TIMI 36 trial. Heart. 2011;97(21):1782–7.
Lee HS, Park YM, Han K, Yang JH, Lee S, Lee SS, et al. Obesity-related hypertension: Findings from the Korea National Health and Nutrition Examination Survey 2008–2010. PLoS One. 2020;15(4):1–14.
Xue Y, Shen Q, Li C, Dai Z, He T. The visceral adipose index in relation to incidence of hypertension in chinese adults: China health and nutrition survey (CHNS). Nutrients. 2020;12(3):1–14.
Ibrahim MM. Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes Rev. 2010;11(1):11–8.
Molica F, Morel S, Kwak B, Steffens S, Rohner-Jeanrenaud F. Adipokines at the crossroad between obesity and cardiovascular disease. Thromb Haemost. 2014;113(03):553–66.
Gielen S, Backer G De, Piepoli MF, Wood D. The ESC Textbook of Preventive Cardiology. Essential Cardiology: Principles and Practice. Oxford: Oxford University Press; 2015.
Lee YC, Lee YH, Chuang PN, Kuo CS, Lu CW, Yang KC. The utility of visceral fat level measured by bioelectrical impedance analysis in predicting metabolic syndrome. Obes Res Clin Pract. 2020;(xxxx).
Rí¸nn PF, Andersen GS, Lauritzen T, Christensen DL, Aadahl M, Carstensen B, et al. Abdominal visceral and subcutaneous adipose tissue and associations with cardiometabolic risk in Inuit, Africans and Europeans: a cross-sectional study. BMJ Open. 2020;10(9):e038071.
Zhang F, Li Y, Zhao Y, Zhou X, Ji L. Is visceral abdominal fat area a better indicator for hyperglycemic risk? Results from the Pinggu Metabolic Disease Study. J Diabetes Investig. 2020;11(4):888–95.
Usui C, Kawakami R, Tanisawa K, Ito T, Tabata H, Iizuka S, et al. Visceral fat and cardiorespiratory fitness with prevalence of pre-diabetes/diabetes mellitus among middle-aged and elderly Japanese people: WASEDA'S Health Study. PLoS One. 2020;15(10 October):1–11.
Wu HT, Chen SC, Fan KC, Kuo CH, Lin SY, Wang SH, et al. Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity. FASEB J. 2020;34(2):2958–67.
Bovolini A, Garcia J, Andrade MA, Duarte JA. Metabolic Syndrome Pathophysiology and Predisposing Factors. Int J Sports Med. 2020.
Copyright (c) 2021 Imam Mahbub Zam Zami, Budi Susetyo Pikir
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Cardiovascular and Cardiometabolic Journal (CCJ) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
-
Authors who publish with Cardiovascular and Cardiometabolic Journal (CCJ) agree to the following terms:
-
The journal allows the author to hold the copyright of the article without restrictions.
-
The journal allows the author(s) to retain publishing rights without restrictions.
-
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution ShareAlike 4.0 International License (CC BY-SA).